<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015667"><a href="http://purl.obolibrary.org/obo/MONDO_0015667">MONDO:0015667</a></h3>
<p><strong>Label:</strong> unclassified acute myeloid leukemia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0007896">MONDO:0007896</a> (acute monocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0011118">MONDO:0011118</a> (acute myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018872">MONDO:0018872</a> (acute megakaryoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017858">MONDO:0017858</a> (acute erythroid leukemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_519">Orphanet:519</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98836">Orphanet:98836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_518">Orphanet:518</a>, <a href="http://purl.obolibrary.org/obo/OMIM_133180">OMIM:133180</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151380">OMIM:151380</a>, <a href="http://www.orpha.net/ORDO/Orphanet_514">Orphanet:514</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601626">OMIM:601626</a>, <a href="http://www.orpha.net/ORDO/Orphanet_318">Orphanet:318</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) 41.37%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 37.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) 36.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system))) 36.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 36.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument))) 36.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin))) 36.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) 32.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 28.96%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002488">HP:0002488</a> (Acute leukemia) 28.72%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 24.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 24.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 23.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 22.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 22.31%</li>
</ul>
</body>
</html>
